Jackson Square Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Jackson Square Capital's BMY Position: Q3 2026 in Review
Jackson Square Capital increased its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2026, buying an estimated $27.5K and bringing the position to 9,925 shares worth $619K. The position accounts for 0.09% of the portfolio, ranked #97.
Jackson Square Capital first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $3.72M in Q1 2026. 514 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Jackson Square Capital held 9,925 shares of Bristol-Myers Squibb worth $619K as of Q3 2026.
- Jackson Square Capital bought 435 Bristol-Myers Squibb shares in Q3 2026, an estimated $27.5K.
- Bristol-Myers Squibb made up 0.09% of Jackson Square Capital's portfolio in Q3 2026, its #97 holding.
- Jackson Square Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
- Jackson Square Capital's Bristol-Myers Squibb position peaked at $3.72M in Q1 2026.
- 514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.